CD8A and influenza: Our data suggest that prophylactic oseltamivir treatment, although causing a marked reduction in influenza-related morbidity, inflammation, and effector CD8+ and CD4+ T cell responses, permits the generation of functional, long-lived, and cross-strain responsive memory CD8+ and CD4+ T cell pools.